Bilge Debeleç-Bütüner

670 total citations
28 papers, 488 citations indexed

About

Bilge Debeleç-Bütüner is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bilge Debeleç-Bütüner has authored 28 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bilge Debeleç-Bütüner's work include Prostate Cancer Treatment and Research (7 papers), DNA Repair Mechanisms (4 papers) and RNA Interference and Gene Delivery (3 papers). Bilge Debeleç-Bütüner is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), DNA Repair Mechanisms (4 papers) and RNA Interference and Gene Delivery (3 papers). Bilge Debeleç-Bütüner collaborates with scholars based in Türkiye, Germany and Czechia. Bilge Debeleç-Bütüner's co-authors include Kemal Korkmaz, Dirk Roggenbuck, Lokman Varışlı, Maria Comănescu, Gina Manda, Adrian Manea, Gheorghița Isvoranu, Syed Muhammad Hamid, Nuray Böğürcü and Ayşe Gülten Kantarcı and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Bilge Debeleç-Bütüner

27 papers receiving 480 citations

Peers

Countries citing papers authored by Bilge Debeleç-Bütüner

Since Specialization

Citations

This map shows the geographic impact of Bilge Debeleç-Bütüner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilge Debeleç-Bütüner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilge Debeleç-Bütüner more than expected).

Fields of papers citing papers by Bilge Debeleç-Bütüner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bilge Debeleç-Bütüner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilge Debeleç-Bütüner. The network helps show where Bilge Debeleç-Bütüner may publish in the future.

Co-authorship network of co-authors of Bilge Debeleç-Bütüner

This figure shows the co-authorship network connecting the top 25 collaborators of Bilge Debeleç-Bütüner. A scholar is included among the top collaborators of Bilge Debeleç-Bütüner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bilge Debeleç-Bütüner. Bilge Debeleç-Bütüner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of selective TYK2 inhibitors: Design, synthesis, in vitro and in silico studies of promising hits with triazolopyrimidinone scaffold 2024 ·Bioorganic Chemistry ·(unknown), (unknown), Ezgi Turunç, (unknown), Bilge Debeleç-Bütüner	3
2	Androgen receptor contributes to repairing DNA damage induced by inflammation and oxidative stress in prostate cancer 2023 ·TURKISH JOURNAL OF BIOLOGY ·Bilge Debeleç-Bütüner, (unknown), (unknown), Dirk Roggenbuck, Kemal Korkmaz	4
3	Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins 2022 ·Frontiers in Immunology ·Bilge Debeleç-Bütüner, (unknown), (unknown), Frank Momburg, Karin Wisskirchen, Ulrike Protzer	6
4	Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition 2022 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Hasan Akbaba, (unknown), İbrahim Çavuş, Črtomir Podlipnik, (unknown), Ahmet Özbilgin, Bilge Debeleç-Bütüner, Vildan Alptüzün	10
5	Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids 2021 ·Journal of Nanobiotechnology ·(unknown), Mustafa Kotmakçı, Anne‐Marie Baird, Steven G. Gray, Bilge Debeleç-Bütüner, Emir Bozkurt, Ayşe Gülten Kantarcı, Stephen P. Finn	44
6	Nutlin3a-Loaded Nanoparticles Show Enhanced Apoptotic Activity on Prostate Cancer Cells 2019 ·Molecular Biotechnology ·Bilge Debeleç-Bütüner, Mustafa Kotmakçı, (unknown), (unknown), Ayşe Gülten Kantarcı	9
7	Cytotoxic Activity of Sesquiterpenoids Isolated from Endemic <i>Ferula tenuissima</i> Hub.-Mor & Peşmen 2019 ·Turkish Journal of Pharmaceutical Sciences ·(unknown), Şüra Baykan, Bilge Debeleç-Bütüner	7
8	Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis 2018 ·Steroids ·Bilge Debeleç-Bütüner, Mert B. Ozturk, (unknown), İsmail Hakkı Akgün, Günay Yetik-Anacak, Erdal Bedi̇r, Kemal Korkmaz	10
9	Detection of 8-OHdG as a diagnostic biomarker 2018 ·Journal of Laboratory and Precision Medicine ·Kemal Korkmaz, Bilge Debeleç-Bütüner, Dirk Roggenbuck	51
10	Use of Non-steroidal Anti-inflammatory Drugs for Chemoprevention of Inflammation-induced Prostate Cancer 2017 ·Turkish Journal of Pharmaceutical Sciences ·Bilge Debeleç-Bütüner, Mert B. Ozturk	1
11	Automated Cell-Based Quantitation of 8-OHdG Damage 2016 ·Methods in molecular biology ·Bilge Debeleç-Bütüner, (unknown), Lisa Heiserich, (unknown), Filiz Özcan, Mutay Aslan, Dirk Roggenbuck, Kemal Korkmaz	4
12	Inflammation contributes to NKX3.1 loss and augments DNA damage but does not alter the DNA damage response via increased SIRT1 expression 2015 ·Journal of Inflammation ·Bilge Debeleç-Bütüner, (unknown), Kemal Korkmaz	17
13	The redox biology network in cancer pathophysiology and therapeutics 2015 ·Redox Biology ·Gina Manda, Gheorghița Isvoranu, Maria Comănescu, Adrian Manea, Bilge Debeleç-Bütüner, Kemal Korkmaz	101
14	TNFα-Mediated Loss of β-Catenin/E-Cadherin Association and Subsequent Increase in Cell Migration Is Partially Restored by NKX3.1 Expression in Prostate Cells 2014 ·PLoS ONE ·Bilge Debeleç-Bütüner, (unknown), (unknown), (unknown), Kutsal Yörükoğlu, Kemal Korkmaz	25
15	HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate 2013 ·Molecular and Cellular Endocrinology ·Syed Muhammad Hamid, (unknown), (unknown), (unknown), Bilge Debeleç-Bütüner, (unknown), Lokman Varışlı, (unknown), Kutsal Yörükoğlu, Kemal Korkmaz	20
16	Inflammation‐mediated abrogation of androgen signaling: An in vitro model of prostate cell inflammation 2012 ·Molecular Carcinogenesis ·Bilge Debeleç-Bütüner, (unknown), Lokman Varışlı, (unknown), Syed Muhammad Hamid, (unknown), Kemal Korkmaz	45
17	Androgen regulated HN1 leads proteosomal degradation of androgen receptor (AR) and negatively influences AR mediated transactivation in prostate cells 2011 ·Molecular and Cellular Endocrinology ·Lokman Varışlı, (unknown), (unknown), Nuray Böğürcü, Bilge Debeleç-Bütüner, (unknown), Kemal Korkmaz	29
18	Ubiquitously Expressed Hematological and Neurological Expressed 1 Downregulates Akt-Mediated GSK3β Signaling, and Its Knockdown Results in Deregulated G2/M Transition in Prostate Cells 2011 ·DNA and Cell Biology ·Lokman Varışlı, (unknown), Bilge Debeleç-Bütüner, (unknown), (unknown), Nuray Böğürcü, Fahri Saatcioglu, Kemal Korkmaz	32
19	NKX3.1 contributes to S phase entry and regulates DNA damage response (DDR) in prostate cancer cell lines 2011 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Lokman Varışlı, (unknown), Bilge Debeleç-Bütüner, (unknown), (unknown), Kemal Korkmaz	8
20	Mutant Telomeric Repeats in Yeast Can Disrupt the Negative Regulation of Recombination-Mediated Telomere Maintenance and Create an Alternative Lengthening of Telomeres-Like Phenotype 2008 ·Molecular and Cellular Biology ·(unknown), Bilge Debeleç-Bütüner, (unknown), (unknown), Zeki Topçu, Michael J. McEachern	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact